Live from the NIH registry
Studies recruiting near Corpus Christi right now
Top 25 of 71 recruiting studies, sorted by proximity — each links to its official registry page
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
Phase 3
Interventional 1,875 participants sought
Driscoll Children's Hospital — Corpus Christi, Texas (5.3 mi)
· Sponsor: National Cancer Institute (NCI)
A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
Childhood Medulloblastoma
Phase 3
Interventional 225 participants sought
Driscoll Children's Hospital — Corpus Christi, Texas (5.3 mi)
· Sponsor: Children's Oncology Group
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Anaplastic Kidney Wilms Tumor, Recurrent Kidney Wilms Tumor
Phase 2
Interventional 256 participants sought
Driscoll Children's Hospital — Corpus Christi, Texas (5.3 mi)
· Sponsor: Children's Oncology Group
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis
Phase 3
Interventional 1,350 participants sought
89bio Clinical Study Site — Corpus Christi, Texas (5.3 mi)
· Sponsor: Hoffmann-La Roche
A Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Moderate to Severe Psoriatic Arthritis
Moderate to Severe Psoriatic Arthritis
Phase 2
Interventional 220 participants sought
Arthritis Care of Texas — Corpus Christi, Texas (5.3 mi)
· Sponsor: Novartis Pharmaceuticals
A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
High Grade Osteosarcoma, Localized Osteosarcoma
Phase 2, Phase 3
Interventional 1,122 participants sought
Driscoll Children's Hospital — Corpus Christi, Texas (5.3 mi)
· Sponsor: National Cancer Institute (NCI)
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
Acute Leukemia of Ambiguous Lineage, B Acute Lymphoblastic Leukemia
Phase 2
Interventional 153 participants sought
Driscoll Children's Hospital — Corpus Christi, Texas (5.3 mi)
· Sponsor: National Cancer Institute (NCI)
Non-healing Venous Leg Ulcers Treated With Standard Care With or Without BR-AC
Non-infected Venous Leg Ulcer, Venous Leg Ulcer
N/A
Interventional 60 participants sought
Site 38 — Corpus Christi, Texas (5.3 mi)
· Sponsor: BioStem Technologies
A Phase 2a/b Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Sjögren's Disease
Sjögren's Disease
Phase 2
Interventional 344 participants sought
Arthritis Care of Texas — Corpus Christi, Texas (5.3 mi)
· Sponsor: Novartis Pharmaceuticals
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma
Phase 3
Interventional 5,951 participants sought
Driscoll Children's Hospital — Corpus Christi, Texas (5.3 mi)
· Sponsor: Children's Oncology Group
A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE)
Diabetes Mellitus, Type 1
Phase 3
Interventional 300 participants sought
Driscoll Children's Hospital — Corpus Christi, Texas (5.3 mi)
· Sponsor: Eli Lilly and Company
Evaluation of Two Monthly Silicone Hydrogel Multifocal Toric in Soft Contact Lens Wearers
Astigmatism, Myopia
N/A
Interventional 60 participants sought
Drs. Mcintyre Garza Avila & Jurica — Corpus Christi, Texas (5.3 mi)
· Sponsor: CooperVision International Limited (CVIL)
A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis
Rheumatoid Arthritis
Phase 2
Interventional 180 participants sought
Arthritis Care Of Texas /ID# 277961 — Corpus Christi, Texas (5.3 mi)
· Sponsor: AbbVie
A Trial to Evaluate Efficacy and Safety of Maridebart Cafraglutide in Adults Living With Elevated Liver Fat and Obesity or Overweight
Overweight or Obesity and Elevated Liver Fat
Phase 2
Interventional 180 participants sought
Pinnacle Clinical Research - Corpus Christi — Corpus Christi, Texas (5.3 mi)
· Sponsor: Amgen
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
NASH With Fibrosis, MASH With Fibrosis
Phase 3
Interventional 1,650 participants sought
Akero Clinical Study Site — Corpus Christi, Texas (5.3 mi)
· Sponsor: Akero Therapeutics, Inc
Proof of Concept Study to Eval MetriDx Lab-developed Test to Identify Endometriosis-specific Bio Markers
Endometriosis, Diagnosis
Phase 2
Interventional 75 participants sought
Corpus Christi Women's Center — Corpus Christi, Texas (5.3 mi)
· Sponsor: Hera Biotech, Inc.
A Study of Orforglipron (LY3502970) Compared With Dulaglutide in Pediatric Participants With Type 2 Diabetes
Diabetes Mellitus, Type 2
Phase 3
Interventional 170 participants sought
Driscoll Children's Hospital — Corpus Christi, Texas (5.3 mi)
· Sponsor: Eli Lilly and Company
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Acute Myeloid Leukemia
Phase 3
Interventional 1,400 participants sought
Driscoll Children's Hospital — Corpus Christi, Texas (5.3 mi)
· Sponsor: Children's Oncology Group
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Breast Cancer
N/A
Observational 30,000 participants sought
CHRISTUS Spohn Cancer Center — Corpus Christi, Texas (5.3 mi)
· Sponsor: Agendia
Impact of Early Fortini Initiation on Growth and Interstage Outcomes in Infants With Single Ventricle Physiology
Single-ventricle
N/A
Interventional 100 participants sought
Driscoll Children's Hospital — Corpus Christi, Texas (5.3 mi)
· Sponsor: Driscoll Children's Hospital
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
Acute Coronary Syndrome
Phase 3
Interventional 2,000 participants sought
Research Site — Corpus Christi, Texas (5.3 mi)
· Sponsor: DalCor Pharmaceuticals
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Driscoll Children's Hospital — Corpus Christi, Texas (5.3 mi)
· Sponsor: National Cancer Institute (NCI)
North American Comfilcon A Clinical Study
Astigmatism, Presbyopia
N/A
Observational 182 participants sought
Drs. McIntyre, Garza, Avila and Jurica, Optometrists — Corpus Christi, Texas (5.3 mi)
· Sponsor: CooperVision International Limited (CVIL)
Efficacy, Safety, and Pharmacokinetics of Tirzepatide (LY3298176) Once Weekly Versus Placebo in Pediatric Participants 6 to Less Than 12 Years of Age Who Have Obesity (ADVANCE-SURMOUNT-KIDS)
Obesity
Phase 3
Interventional 150 participants sought
Driscoll Children's Hospital — Corpus Christi, Texas (5.3 mi)
· Sponsor: Eli Lilly and Company
A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)
Stage I Mixed Cell Type Kidney Wilms Tumor, Stage II Mixed Cell Type Kidney Wilms Tumor
Phase 3
Interventional 1,656 participants sought
Driscoll Children's Hospital — Corpus Christi, Texas (5.3 mi)
· Sponsor: Children's Oncology Group